Oral FluidCompared to other drug test specimen types like urine, and especially hair, oral fluid generally detects drugs sooner after use. It takes time for drugs, like marijuana, to metabolize and pass through the donor’s system, but an oral fluid test will often detect the presence of drugs almost immediately after use. As such, oral fluid is ideal for a number of testing situations including pre-employment, random and post-accident testing where the indication of recent use can be an important consideration.

The latest data from the Quest Diagnostics Drug Testing Index™ (DTI) reports that the detection of marijuana in oral fluid has increased for the second consecutive year. Oral fluid positivity rates for marijuana climbed 27 percent (5.1% vs. 4.0%) in 2013 compared to 2012 after a dramatic increase of 48 percent (4.0% vs. 2.7%) in 2012 compared to 2011. While the trend of higher positivity rates may be partially attributed to an uptick in marijuana use among testing subjects, other variables including observed collections associated with oral fluid testing and the introduction of Quest Diagnostics new oral fluid testing technology in 2011 are also contributing factors to the increase in oral fluid marijuana positivity rates.

To learn more about the recent trends in prescription drug use, read the full release at QuestDiagnostics.com/DTI or download the new brochure. You can also subscribe to get email updates containing the latest DTI information.

Drug Test Collections Video

by Landon Todd on November 10, 2014

collections_video.jpgAs part of our we’re there when you need us™ commitment, we strive to continually educate employers about the variety of available drug testing solutions, products and services. With this in mind, video is an effective teaching tool and is one of the many resources we use to educate our clients. Our most recent video is available on our YouTube channel, DrugTestingTV, and highlights our different drug test collection services and the benefits of each.

When choosing a drug test collection service provider, there are several options to consider. We provide unparalleled access to a nationwide network of more than 8,000 collection sites. And for those situations when a donor is unable to visit a collection site, we provide on-site services for scheduled or 24/7 emergency collections. Each type of collection service provides unique benefits and it’s important to know the differences when evaluating the array of options and alternatives.

Watch our new video, Drug Test Collections, to learn more about our broad menu of collection services.

Oxycodones Positivity Declines for the Second Consecutive Year

November 6, 2014 Industry News

For people with chronic and reoccurring pain, opioids, such as hydrocodone and oxycodones, not only relieve suffering, but can also help support a normal lifestyle, alleviate stress and improve sleep. These drugs work by reducing the intensity of pain signals reaching the brain and affect the areas of the brain that control emotion, which diminishes […]

Read the full article →

Dangers of Synthetic Cannabinoids

November 3, 2014 Quest News

Synthetic cannabinoid use continues because many users assume it is safe. The packaging displays a “not for human consumption” message, yet users continue to smoke the substance to replicate a high similar to marijuana. Adverse effects of synthetic cannabinoids include severe agitation, anxiety, nausea, vomiting, tachycardia (racing heartbeat), elevated blood pressure, tremors, seizures, hallucinations, paranoid […]

Read the full article →

Busting the Top 10 Marijuana Myths

October 31, 2014 Illicit Drugs

The latest data from the Quest Diagnostics Drug Testing Index™ (DTI) reports that marijuana continues to be the most commonly detected illicit drug. Analysis of more than 7.6 million urine drug tests shows marijuana positivity in the combined U.S. workforce increased 6.2 percent, to 1.7 percent in 2013 compared to 1.6 percent in 2012. With […]

Read the full article →

Ebola and Workplace Drug Testing Programs

October 30, 2014 Industry News

The Ebola Virus Disease (EVD) is an infectious disease that has rapidly spread in parts of West Africa. In recent weeks, cases of infected individuals have been reported in the United States. A consequence of the high profile of the virus has been the heightened need for workplaces to react appropriately in order to help […]

Read the full article →

Methamphetamine Positivity Increases Across All Testing Types

October 24, 2014 Illicit Drugs

Amphetamines, which includes Methamphetamine, are a distinct class of drugs that stimulate the central nervous system producing an increase in alertness and awareness. Methamphetamine releases high levels of the neurotransmitter dopamine, which stimulates brain cells, enhancing mood and body movement. Methamphetamine is made using relatively inexpensive over-the-counter ingredients which gives it a high potential for […]

Read the full article →

Avoid Common Employer Substance Abuse Prevention Program Mistakes

October 17, 2014 Quest News

Today, 14.6 million employees in the United States are current drug users, meaning the employee has used an illicit drug at least once in the past month. Substance abuse in the workplace adversely impacts performance, attendance, safety and health care costs. Our presenter, Mark A. de Bernardo, is a nationally recognized expert in workplace drug testing and substance […]

Read the full article →

Workplace Opioid Use is Costing Employers

October 15, 2014 Quest News

A recent Wall Street Journal article highlights the impact of the increasing use of heroin and opioids in the workplace and its financial toll. Employers are struggling with a rise in accidents, theft, absenteeism and turnover as well as reduced productivity due to drug abuse. The article tells the story of how drug use is “afflicting the […]

Read the full article →

October is National Substance Abuse Prevention Month

October 13, 2014 Industry News

The latest data from the Quest Diagnostics Drug Testing Index™ (DTI) reports that the positivity rate for 7.6 million urine drug tests in the combined U.S. workforce increased to 3.7 percent in 2013, compared to 3.5 percent in 2012. The relative increase of 5.7 percent year-over-year is the first time the positivity rate for combined […]

Read the full article →